WallStreetZenWallStreetZen

NASDAQ: PTPI
Petros Pharmaceuticals Inc Stock

$2.66-0.04 (-1.48%)
Updated Feb 3, 2023
PTPI Price
$2.66
Fair Value Price
$543.04
Market Cap
$5.51M
52 Week Low
$1.91
52 Week High
$28.80
P/E
-0.18x
P/B
0.27x
P/S
2.44x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.33M
Earnings
-$24.00M
Gross Margin
61.8%
Operating Margin
-544%
Profit Margin
-554.7%
Debt to Equity
0.82
Operating Cash Flow
-$20M
Beta
1.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PTPI Overview

Petros Pharmaceuticals, Inc. develops and commercializes therapeutics for men's health issues (erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, peyronie's disease, hormone health, and substance use disorders). lt markets its own line of ED products in the form of vacuum erection devices through its subsidiary, Timm Medical, Inc. Petros Pharmaceuticals was founded in 2020 and is headquartered in New York, NY.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PTPI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PTPI ($2.66) is undervalued by 99.51% relative to our estimate of its Fair Value price of $543.04 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PTPI ($2.66) is significantly undervalued by 99.51% relative to our estimate of its Fair Value price of $543.04 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PTPI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PTPI due diligence checks available for Premium users.

Be the first to know about important PTPI news, forecast changes, insider trades & much more!

PTPI News

Valuation

PTPI fair value

Fair Value of PTPI stock based on Discounted Cash Flow (DCF)
Price
$2.66
Fair Value
$543.04
Undervalued by
99.51%
PTPI ($2.66) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PTPI ($2.66) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PTPI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PTPI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.18x
Industry
18.24x
Market
15.09x

PTPI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.27x
Industry
1.9x
PTPI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PTPI's financial health

Profit margin

Revenue
-$1.5M
Net Income
-$13.8M
Profit Margin
948.7%
PTPI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PTPI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$37.7M
Liabilities
$17.0M
Debt to equity
0.82
PTPI's short-term assets ($18.77M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PTPI's short-term assets ($18.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PTPI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.8M
Investing
$0.0
Financing
-$362.0k
PTPI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PTPI vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
PTPI$5.51M-1.48%-0.18x0.27x
PRFX$5.26M+5.10%-0.71x0.39x
CPHI$5.78M+3.70%-1.40x2.04x
SNOA$5.09M+0.61%-0.82x0.72x
AKAN$7.89M-11.65%N/A0.23x

Petros Pharmaceuticals Stock FAQ

What is Petros Pharmaceuticals's quote symbol?

NASDAQ: PTPI) Petros Pharmaceuticals trades on the NASDAQ under the ticker symbol PTPI. Petros Pharmaceuticals stock quotes can also be displayed as NASDAQ: PTPI.

If you're new to stock investing, here's how to buy Petros Pharmaceuticals stock.

What is the 52 week high and low for Petros Pharmaceuticals (NASDAQ: PTPI)?

(NASDAQ: PTPI) Petros Pharmaceuticals's 52-week high was $28.80, and its 52-week low was $1.91. It is currently -90.76% from its 52-week high and 39.27% from its 52-week low.

How much is Petros Pharmaceuticals stock worth today?

(NASDAQ: PTPI) Petros Pharmaceuticals currently has 2,070,802 outstanding shares. With Petros Pharmaceuticals stock trading at $2.66 per share, the total value of Petros Pharmaceuticals stock (market capitalization) is $5.51M.

Petros Pharmaceuticals stock was originally listed at a price of $39.90 in Dec 2, 2020. If you had invested in Petros Pharmaceuticals stock at $39.90, your return over the last 2 years would have been -93.33%, for an annualized return of -74.18% (not including any dividends or dividend reinvestments).

How much is Petros Pharmaceuticals's stock price per share?

(NASDAQ: PTPI) Petros Pharmaceuticals stock price per share is $2.66 today (as of Feb 3, 2023).

What is Petros Pharmaceuticals's Market Cap?

(NASDAQ: PTPI) Petros Pharmaceuticals's market cap is $5.51M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Petros Pharmaceuticals's market cap is calculated by multiplying PTPI's current stock price of $2.66 by PTPI's total outstanding shares of 2,070,802.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.